Surgery Doctors in Chesterfield, MI Accepting Medicare

1 Surgery doctors found. Showing 1 - 1

Robert A Valice, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 32743 23 Mile Rd Ste 110, Chesterfield, MI 48047 Phone: 586-725-3444    Fax: 586-725-0984

News Archive

Scientists identify potential treatment for idiopathic pulmonary fibrosis

Investigators at the University of Alabama at Birmingham (UAB) have unlocked another piece of the puzzle surrounding idiopathic pulmonary fibrosis, an often fatal lung disease with no cure and no effective treatments.

Air pollution associated with greater virulence of COVID-19

A new study published on the preprint server medRxiv* in April 2020 provides convincing evidence that air pollution contributes to greater severity of COVID-19. The researchers say, "This suggests the detrimental impact climate change will have on the trajectory of future respiratory epidemics."

Study confirms neurobiological origin of attention-deficit disorder

A study, carried out on mice, has just confirmed the neurobiological origin of attention-deficit disorder (ADD), a syndrome whose causes are poorly understood. Researchers from CNRS, the University of Strasbourg and INSERM1 have identified a cerebral structure, the superior colliculus, where hyperstimulation causes behavior modifications similar to those of some patients who suffer from ADD.

Brainlab launches automated stereotactic radiosurgery planning tools at ESTRO 2015

The "Elements" strategy - indication-specific focused software applications aimed at enhancing the workflow for difficult to treat indications in the brain and spine introduced in 2013 - comes full circle with the introduction of automated stereotactic radiosurgery (SRS) planning tools. These new Elements enable on-the-fly generation of consistent treatment plans for VMAT delivery.

Launch Excellence Services provides solutions to new pharma product market entry

The pressure for a new product to succeed at launch has never been greater with organizations across the pharmaceutical sector facing pipeline deficits, patent expirations and increasing development costs.

Read more Medical News

› Verified 4 days ago